1. Combined Ang-2 and VEGF Targeting Therapies in Renal Cell Carcinoma
   Nikolett Molnar et al, 2013, Journal of Cancer Therapy CrossRef
2. Vulnerable Plaque, Characteristics, Detection, and Potential Therapies
   Anouar Hafiane, 2019, Journal of Cardiovascular Development and Disease CrossRef
3. New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness
   Isabel Corraliza-Gorjón et al, 2017, Frontiers in Immunology CrossRef
4. Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade
   Weiwei Zheng et al, 2022, Frontiers in Immunology CrossRef
5. Insertion of scFv into the hinge domain of full-length IgG1 monoclonal antibody results in tetravalent bispecific molecule with robust properties
   Binyam Bezabeh et al, 2017, mAbs CrossRef
6. A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
   Deok-Hoon Kong et al, 2017, International Journal of Molecular Sciences CrossRef
7. Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease
   Daniel G. Sedding et al, 2018, Frontiers in Immunology CrossRef
8. Ang2-Targeted Combination Therapy for Cancer Treatment
   Na Liu et al, 2022, Frontiers in Immunology CrossRef
9. The Emerging Roles of Pericytes in Modulating Tumor Microenvironment
   Ruipu Sun et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
10. Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets
    Harshini Chakravarthy et al, 2018, Journal of Molecular Neuroscience CrossRef
11. Identification and Preliminary SAR Analysis of Novel Type-I Inhibitors of TIE-2 via Structure-Based Virtual Screening and Biological Evaluation in in vitro Models
    Peichen Pan et al, 2015, Journal of Chemical Information and Modeling CrossRef
12. Tumor angiogenesis and vascular normalization: alternative therapeutic targets
    Claire Viallard et al, 2017, Angiogenesis CrossRef
13. Neue Wege zur zielgerichteten Prävention und Behandlung der Atherosklerose
    Axel Haverich et al, 2023, Atherosklerose-Pathogenese und mikrovaskuläre Dysfunktion CrossRef
14. Inhibition of endothelial/smooth muscle cell contact loss by the investigational angiopoietin-2 antibody MEDI3617
    Nikolett Molnar et al, 2012, Microvascular Research CrossRef
15. New Ways to Target Vasa Vasorum for the Prevention and Treatment of Atherosclerosis
    Axel Haverich et al, 2019, Atherosclerosis Pathogenesis and Microvascular Dysfunction CrossRef
16. Therapeutic Targets and Tumor Microenvironment in Colorectal Cancer
    Gaetano Gallo et al, 2021, Journal of Clinical Medicine CrossRef